Screening for reducing morbidity and mortality in malignant melanoma-Reference-Cited by-同舟云学术

Screening for reducing morbidity and mortality in malignant melanoma

Published:2019-06-03 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Johansson Minna¹,Brodersen John²³⁴,Gøtzsche Peter C⁵,Jørgensen Karsten Juhl⁵

Affiliation:

1. Cochrane Sweden; Hedegatan 38 Uddevalla Sweden 45152

2. University of Copenhagen; The Section of General Practice, Department of Public Health, Faculty of Health Sciences, Center for Health and Society; Copenhagen Denmark

3. University of Copenhagen; The Research Unit for General Practice, Department of Public Health, Faculty of Health Sciences, Center for Health and Society; Copenhagen Denmark

4. Zealand Region; Primary Healthcare Research Unit; Copenhagen Denmark

5. Rigshospitalet; Nordic Cochrane Centre; Blegdamsvej 9, 7811 Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012352.pub2/epdf/full

Reference96 articles.

1. A randomised trial of population screening for melanoma;Aitken;Journal of Medical Screening,2002

2. Clinical outcomes from skin screening clinics within a community-based melanoma screening program;Aitken;Journal of the American Academy of Dermatology,2006

3. Increase in skin cancer screening during a community-based randomized intervention trial;Aitken;International Journal of Cancer,2006